MiMedx Group Inc expected to post a loss of 4 cents a share - Earnings Preview

MiMedx

25/02/2023 03:01

* MiMedx Group Inc  MDXG.OQ   MDXG.O  is expected to show a
rise
in quarterly revenue when it reports  results on February 28. 
    * The Marietta Georgia-based  company is expected to report 
a
10.6% increase in revenue to $74.529 million from $67.41 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. The company's guidance on January 9
2023, for the period ended December 31, was for revenue between
$73.00 million and $76.00 million.
    * ​Refinitiv's mean analyst estimate for MiMedx Group Inc is
for a
loss of 4 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for MiMedx
Group Inc
is $9​, above​ its last closing price of $4.50. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.07       -0.08      -0.09     Missed  -16.1
 Jun. 30 2022  -0.05       -0.06      -0.11     Missed  -94.1
 Mar. 31 2022  -0.10       -0.10      -0.11     Missed  -10​
 Dec. 31 2021  -0.02       -0.03      0.01      Beat    130
 ​​Sep.        -0.08       -0.08      -0.04     Beat    50
 30 2021                                                
 Jun. 30 2021  -0.08       -0.07      -0.03     Beat    59.1​
 Mar. 31 2021  -0.19       -0.19      -0.09     Beat    52.6
 Dec. 31 2020  -0.05       -0.05      -0.17     Missed  -240
 This summary was machine generated February 25 at 03:01 GMT. 
All figures in US dollars  unless otherwise stated